That's one question / reservation I have. It appears they've taken substantial market share in the lactose-free category, mostly from Zymil, as well as from plant alternatives. But how much are they likely to cannibalize their own sales of standard A2 fresh milk? No doubt it's a net win in terms of overall sales revenue but might be a constraining factor nonetheless.
Some people who have digestive issues from milk may might not be bothered ascertaining whether it is lactose intolerance or sensitivity to A1 protein. Might as well go straight to the choice that eliminates both of these potential causes (A2 Lactose Free). Still, it tastes nowhere near as good as the regular A2 milk, so I doubt many would continue drinking it unless they really had to.
A2M Price at posting:
$6.69 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)